Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin–Angiotensin System Activation in Experimental Type 1 Diabetes

DOI Web Site PubMed 4 Citations 138 References
  • Kamiyama Masumi
    Department of Physiology, Tulane University Health Sciences Center, USA Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, USA
  • Zsombok Andrea
    Department of Physiology, Tulane University Health Sciences Center, USA Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, USA Department of Medicine, Tulane University Health Sciences Center, USA
  • Kobori Hiroyuki
    Department of Physiology, Tulane University Health Sciences Center, USA Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, USA Department of Medicine, Tulane University Health Sciences Center, USA

Bibliographic Information

Other Title
  • Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin^|^ndash;Angiotensin System Activation in Experimental Type 1 Diabetes

Search this article

Description

Urinary excretion of albumin (UAlb) is used clinically as a marker of diabetic nephropathy (DN). Although DN was thought to be a unidirectional process, recent studies demonstrated that a large proportion of patients diagnosed with DN reverted to normoalbuminuria. Moreover, despite the normoalbuminuria, one-third of them exhibited reduced renal function even during the microalbuminuric stage. This study was performed to investigate whether urinary angiotensinogen (UAGT) level may serve as a useful marker of the early stage of experimental type 1 diabetes (T1DM). T1DM was induced by a single intraperitoneal injection of streptozotocin. Control mice were injected with citrate buffer. Two days after streptozotocin injection, half of the mice received continuous insulin treatment. Our data showed that UAlb excretion was increased 6 days after streptozotocin injection compared to controls, whereas UAGT excretion was increased at an earlier time point. These increases were reversed by insulin treatment. The UAGT to UAlb ratio was increased in diabetic mice compared to control mice. Furthermore, the increased AGT expression in the kidneys was observed in diabetic mice. These data suggest that UAGT might be useful as a novel early biomarker of activation of the renin–angiotensin system in experimental type 1 diabetes.

Journal

Citations (4)*help

See more

References(138)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top